• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物所致迟发性运动障碍的药物遗传学评估:5-羟色胺2C受体基因以及多巴胺D3变异等位基因(甘氨酸)与锰超氧化物歧化酶野生等位基因(缬氨酸)组合的作用

[Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].

作者信息

Zhang Zhijun, Hou Gang, Zhang Xiaobin, Yao Hui, Sha Weiwei, Zhang Xinbao

机构信息

Department of Psychiatry and Clinical Science Center, Nanjing Brain Hospital, Nanjing Medical University, Nanjing, Jiangsu, 210029 P. R. China. zhijunzhang616@hotmail. com

出版信息

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Apr;20(2):98-102.

PMID:12673575
Abstract

OBJECTIVE

To further investigate whether the functional polymorphisms of dopamine D2 receptor (DRD2) and dopamine D3 receptor (DRD3) genes associate with the development of tardive dyskinesia (TD) in schizophrenia, and whether the interactive effects of DRD2, DRD3, 5-hydroxytryptamine 2C receptor (HTR2C) and manganese superoxide dismutase (MnSOD) genes contribute to the severity of TD.

METHODS

The patients with schizophrenia were assessed for TD by the Abnormal Involuntary Movement Scale (AIMS). Eventually, 42 schizophrenics with persistent TD were in the TD group, and 59 schizophrenics without TD were in the non-TD group. The polymorphism of each candidate gene was analyzed using a polymerase chain reaction-based restriction fragment length polymorphism analysis.

RESULTS

The genotype distributions of the candidate genes in the groups were all consistent with the Hardy-Weinberg equilibrium. Allele frequencies for -759C/T and -697G/C polymorphisms in HTR2C gene showed a significant excess of -697 variant (P<0.05) in the patients with TD, compared against those in patients without TD. There were no differences in the distributions of the allelic frequencies and genotypes of Taq I. A polymorphism in DRD2 gene, of Ser/Gly polymorphism in DRD3 gene, and of Ala-9Val polymorphism in MnSOD gene between the TD group and non-TD group (P>0.05). Interestingly, as compared with the other joint allelic types, a significant excess of carrying both DRD3 variant allele (Gly) and MnSOD wild allele (Val) was found in the TD group (P<0.05). However, neither the allele and genotypes nor the clinical demographic characteristics contributed to the higher total AIMS scores in the patients of the TD group. There were no significant differences in any of the clinical demographic characteristics between the subgroups of any genotype in TD and non-TD groups.

CONCLUSION

The excess of -697 variant in the promoter regulation region of the HTR2C gene may be a risk factor for the susceptibility to the occurrence of TD in Chinese male patients with schizophrenia. A combination of DRD3 variant allele (Gly) and MnSOD wild allele (Val) may increase the susceptibility to the development of TD.

摘要

目的

进一步研究多巴胺D2受体(DRD2)基因和多巴胺D3受体(DRD3)基因的功能多态性是否与精神分裂症迟发性运动障碍(TD)的发生相关,以及DRD2、DRD3、5-羟色胺2C受体(HTR2C)和锰超氧化物歧化酶(MnSOD)基因的交互作用是否影响TD的严重程度。

方法

采用异常不自主运动量表(AIMS)对精神分裂症患者进行TD评估。最终,42例持续性TD的精神分裂症患者纳入TD组,59例无TD的精神分裂症患者纳入非TD组。采用聚合酶链反应-限制性片段长度多态性分析方法分析各候选基因的多态性。

结果

各候选基因在两组中的基因型分布均符合Hardy-Weinberg平衡。与非TD患者相比,TD患者中HTR2C基因-759C/T和-697G/C多态性的等位基因频率显示-697变异体显著过量(P<0.05)。TD组和非TD组之间,DRD2基因的Taq I多态性、DRD3基因的Ser/Gly多态性以及MnSOD基因的Ala-9Val多态性在等位基因频率和基因型分布上没有差异(P>0.05)。有趣的是,与其他联合等位基因类型相比,TD组中同时携带DRD3变异等位基因(Gly)和MnSOD野生等位基因(Val)的情况显著过量(P<0.05)。然而,等位基因和基因型以及临床人口统计学特征均未导致TD组患者的AIMS总分更高。TD组和非TD组中任何基因型亚组之间的任何临床人口统计学特征均无显著差异。

结论

HTR2C基因启动子调控区-697变异体过量可能是中国男性精神分裂症患者发生TD易感性的一个危险因素。DRD3变异等位基因(Gly)和MnSOD野生等位基因(Val)的组合可能增加发生TD的易感性。

相似文献

1
[Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].抗精神病药物所致迟发性运动障碍的药物遗传学评估:5-羟色胺2C受体基因以及多巴胺D3变异等位基因(甘氨酸)与锰超氧化物歧化酶野生等位基因(缬氨酸)组合的作用
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Apr;20(2):98-102.
2
Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.中国精神分裂症患者中CYP2D6和CYP1A2基因多态性与迟发性运动障碍的关联
Acta Pharmacol Sin. 2006 Mar;27(3):328-32. doi: 10.1111/j.1745-7254.2006.00279.x.
3
[Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].[波兰中部患有迟发性运动障碍的精神分裂症患者的锰超氧化物歧化酶基因(MnSOD)多态性]
Psychiatr Pol. 2006 Sep-Oct;40(5):937-48.
4
Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.韩国精神分裂症患者中多巴胺D3受体基因Ser9Gly多态性与迟发性运动障碍的关联
Psychiatry Clin Neurosci. 2002 Aug;56(4):469-74. doi: 10.1046/j.1440-1819.2002.01038.x.
5
Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.锰超氧化物歧化酶(MnSOD:丙氨酸-9缬氨酸)基因多态性可能与精神分裂症和迟发性运动障碍无关。
Psychiatry Res. 2007 Sep 30;153(1):77-81. doi: 10.1016/j.psychres.2006.04.011. Epub 2007 Jun 19.
6
No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.精神分裂症患者中多巴胺D4受体基因-521 C/T多态性与迟发性运动障碍之间无关联。
Neuropsychobiology. 2007;55(1):47-51. doi: 10.1159/000103576. Epub 2007 Jun 8.
7
Cebus apella, a nonhuman primate highly susceptible to neuroleptic side effects, carries the GLY9 dopamine receptor D3 associated with tardive dyskinesia in humans.僧帽猴是一种对精神抑制药物副作用高度敏感的非人类灵长类动物,它携带与人类迟发性运动障碍相关的GLY9多巴胺受体D3。
Pharmacogenomics J. 2003;3(2):97-100. doi: 10.1038/sj.tpj.6500152.
8
Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.锰超氧化物歧化酶Ala-9Val多态性与科萨族人群精神分裂症及异常不自主运动发生之间的关联
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):664-72. doi: 10.1016/j.pnpbp.2006.12.019. Epub 2007 Jan 12.
9
Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.精神分裂症患者多巴胺降解酶(儿茶酚-O-甲基转移酶和单胺氧化酶)基因多态性与迟发性运动障碍
Psychiatry Res. 2004 Jun 30;127(1-2):1-7. doi: 10.1016/j.psychres.2004.03.011.
10
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.迟发性运动障碍的药物遗传学:780例患者的联合分析支持与多巴胺D3受体基因Ser9Gly多态性相关
Neuropsychopharmacology. 2002 Jul;27(1):105-19. doi: 10.1016/S0893-133X(02)00293-2.

引用本文的文献

1
Tardive Dyskinesia Development, Superoxide Dismutase Levels, and Relevant Genetic Polymorphisms.迟发性运动障碍的发展、超氧化物歧化酶水平与相关基因多态性
Oxid Med Cell Longev. 2022 Oct 28;2022:5748924. doi: 10.1155/2022/5748924. eCollection 2022.